NB
Nabriva Therapeutics plc
NBRVF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $323.0
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.00x
P/S 0.00x
EV/EBITDA N/A
Growth
78 /100
Growing Book val. growth 56.95%
Rev. growth 66.35%
FCF growth N/A
Profitability
6 /100
Weak Net margin 160.33%
Op. margin 155.57%
FCF margin 103.52%
Quality
20 /100
Poor ROA 180.03%
Asset turnover 1.12x
ROIC 634.43%
Debt
51 /100
Moderate Current ratio 1.13x
Int. coverage -78.68x
Net debt/EBITDA 0.13x
Stability
35 /100
Moderate Rev. volatility 258.14%
EPS volatility 26.83%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NBRVF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
H. Michael Hogan
Employees
39
Headquarters
Dublin
Prihajajoči dogodki
13 NOV.
Earnings
Upcoming earnings report